Health Care [ 9/12 ] | Biotechnology [ 36/73 ]
NASDAQ | Common Stock
Oculis Holding AG, a clinical-stage biopharmaceutical company, develops drug candidates to treat ophthalmic diseases in Switzerland, Iceland, and internationally.
The company's lead product candidate is OCS-01, a topical dexamethasone optireach formulation, which is in Phase 3 clinical trials for the treatment of diabetic macular edema; OCS-02, a topical biologic candidate that is in Phase 2b clinical trials for the treatment for dry eye disease; and OCS-05, a disease modifying neuroprotective agent for neurological damage with indications for glaucoma, dry age-related macular degeneration and diabetic retinopathy, and acute optic neuritis.
Oculis Holding AG was formerly known as Oculis SA and changed its name to Oculis Holding AG in March 2023.
The company was founded in 2017 and is based in Zug, Switzerland.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Aug 21, 25 | -0.49 Increased by +3.92% | -0.46 Decreased by -6.52% |
| May 8, 25 | -0.69 Decreased by -56.82% | -0.46 Decreased by -50.00% |
| Mar 11, 25 | -0.67 Decreased by -97.06% | -0.43 Decreased by -55.81% |
| Nov 7, 24 | -0.48 Increased by 0.00% | -0.42 Decreased by -13.37% |
| Aug 27, 24 | -0.51 Decreased by -34.21% | -0.37 Decreased by -36.58% |
| May 9, 24 | -0.44 Increased by +70.86% | -0.40 Decreased by -10.00% |
| Mar 18, 24 | -0.34 Decreased by -466.67% | -0.42 Increased by +19.05% |
| Nov 15, 23 | -0.48 Decreased by -2.30 K% | -0.32 Decreased by -50.00% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Jun 30, 25 | 0.00 Decreased by -100.00% | -25.38 M Decreased by -21.77% | Decreased by N/A% Decreased by N/A% |
| Mar 31, 25 | 0.00 Decreased by -100.00% | -33.21 M Decreased by -106.38% | Decreased by N/A% Decreased by N/A% |
| Dec 31, 24 | 0.00 Decreased by -100.00% | -28.66 M Decreased by -129.26% | Decreased by N/A% Decreased by N/A% |
| Sep 30, 24 | 0.00 Decreased by -100.00% | -20.19 M Decreased by -15.95% | Decreased by N/A% Decreased by N/A% |
| Jun 30, 24 | 245.00 K Decreased by -2.00% | -20.84 M Decreased by -61.83% | Decreased by -8.51 K% Decreased by -65.13% |
| Mar 31, 24 | 222.00 K Decreased by -7.31% | -16.09 M Increased by +65.03% | Decreased by -7.25 K% Increased by +62.27% |
| Dec 31, 23 | 185.00 K Decreased by -13.55% | -12.50 M Decreased by -36.11% | Decreased by -6.76 K% Decreased by -57.45% |
| Sep 30, 23 | 219.00 K Increased by +8.42% | -17.41 M Decreased by -74.93% | Decreased by -7.95 K% Decreased by -61.36% |